The initiative, which includes stakeholders from government, industry, academia, patient advocacy groups, professional societies, and other organizations, has the goal of identifying practices whose broad adoption will increase the quality and efficiency of clinical trials.9 In clinical trials, most of the costs are associated with human time and effort, so unnecessary complexity can be both burde